Preparation method of BTK inhibitor drug intermediate
A novel synthesis method for BTK inhibitor drug intermediates addresses the inefficiencies of existing processes by providing a higher yield and simpler operation, suitable for industrial production.
Patent Information
- Application Number
- CN202411208226.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-30
- Publication Date
- 2024-12-03
- Estimated Expiration
- 2044-08-30
AI Technical Summary
The existing preparation process for BTK inhibitor drug intermediates is lengthy and has low yield, making it unsuitable for industrial-scale production.
A novel synthesis method involving specific chemical reactions and conditions, including the use of solvents, reagents, and reaction parameters, to efficiently produce BTK inhibitor drug intermediates with higher yield and simplicity.
The method achieves a higher yield and purity with fewer steps, making it suitable for industrial applications.
Smart Images

Figure CN119059970A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to a method for preparing a BTK inhibitor drug intermediate. Background Art
[0002] Mutations in the Bruton's tyrosine kinase (BTK) gene cause a rare inherited B-cell-specific immunodeficiency disease called X-linked agammaglobulinemia (XLA). In this disease, BTK function is inhibited, resulting in blocked production or maturation of B cells. Men with XLA disease have virtually no B cells in their bodies, few circulating antibodies, and are prone to severe or even fatal infections. This strongly proves that BTK plays an extremely important role in the growth and differentiation of B cells.
[0003] CN107382973B provides a 5-aminopyrazolecarboxamide derivative as a BTK inhibitor, a preparation method and a pharmaceutical composition thereof, as shown in formula (1):
[0004]
[0005] This class of compounds is an effective and safe inhibitor of protein kinase BTK. However, the preparation process disclosed therein has the disadvantages of long route, low yield and disadvantageous for industrialization. Therefore, it is urgent to provide a process route with high yield and industrialization scale-up to efficiently prepare the target compound. Summary of the invention
[0006] The technical problem to be solved by the present invention is to provide a new preparation method of a BTK inhibitor drug intermediate, which can more effectively synthesize BTK inhibitor drugs. The preparation method provided by the present invention has fewer steps, is easy to operate, and has a higher yield.
[0007] The present invention solves the above technical problems through the following technical solutions.
[0008] The present invention provides a method for preparing a compound as shown in formula I, comprising the following steps:
[0009]
[0010] Step 1, in a solvent, compound B3, ethyl Grignard reagent, titanate and boron trifluoride reagent react to generate compound B4;
[0011] Step 2, compound B4 reacts with an acid to generate compound B5;
[0012] Step 3, in a solvent, compound B5 reacts with benzyl chloroformate (CbzCl) and a base to generate compound B6;
[0013] Step 4, in a solvent, in the presence of a base and potassium phosphate, compound B6 reacts with p-toluenesulfonyl chloride (TsCl) and di-tert-butyltin dichloride (Bu2SnCl2) to generate compound B7;
[0014] Step 5, in a solvent and in the presence of an acid, compound B7 reacts with 3,4-dihydropyran to generate compound B7-1;
[0015] Step 6, in a solvent, compound B7-1 reacts with a base to generate compound B7-2;
[0016] Step 7, in a solvent, compound B7-2 reacts with an acid to generate compound B8;
[0017] Step 8, in a solvent, compound B8 and compound B8-1 undergo Mitsunobu reaction to generate compound B9;
[0018] Step 9, in a solvent, compound B9 reacts with ethanolamine to generate compound B10;
[0019] Step 10, in a solvent, compound B10 reacts with an acid to generate compound I.
[0020] In the preparation method, in step 1, the solvent may be a conventional solvent for such reactions in the art, such as an ether solvent, preferably methyl tert-butyl ether.
[0021] In the preparation method, in step 1, the ethyl Grignard reagent may be ethylmagnesium bromide.
[0022] In the preparation method, in step 1, the concentration of the ethyl grignard reagent can be 1M.
[0023] In the preparation method, in step 1, the titanate may be tetraisopropyl titanate.
[0024] In the preparation method, in step 1, the boron trifluoride reagent can be boron trifluoride etherate.
[0025] In the preparation method, in step 1, the concentration of the compound B3 in the solvent may be 0.1-1 kg / L, preferably 0.1 kg / L.
[0026] In the preparation method, in step 1, the molar ratio of the compound B3 to the ethyl Grignard reagent can be 1:(10-20); preferably 1:16.
[0027] In the preparation method, in step 1, the molar ratio of the compound B3 to the titanate may be (0.5-2):1; preferably 0.9:1.
[0028] In the preparation method, in step 1, the molar ratio of the compound B3 to the boron trifluoride reagent can be (0.5~1):1; preferably 0.52:1.
[0029] In the preparation method, in step 1, the reaction temperature can be 10-20°C.
[0030] In the preparation method, in step 1, the reaction is carried out under the protection of an inert gas, such as nitrogen.
[0031] In the preparation method, step 1 comprises the following steps: under nitrogen protection, adding compound B3 and tetraisopropyl titanate to methyl tert-butyl ether, adding ethyl magnesium bromide dropwise at 10-20° C., and after the reaction is complete, continuing to add boron trifluoride ether dropwise at 10-20° C. to obtain a solution containing compound B4.
[0032] In the preparation method, in step 1, the compound B4 generated by the reaction is directly used in step 2 without post-treatment.
[0033] In the preparation method, in step 2, the acid may be a citric acid aqueous solution; the concentration of the citric acid aqueous solution is preferably 25% or 5%.
[0034] In the preparation method, in step 2, the molar ratio of the compound B4 to the acid can be 1:(1-2); preferably 1:1.8.
[0035] In the preparation method, in step 2, the reaction temperature can be 20-40°C.
[0036] In the preparation method, step 2 comprises the following steps: adding 25% citric acid aqueous solution to the solution containing compound B4 obtained in step 1 at 20-40°C, stirring at 15-35°C, standing to separate layers, extracting the organic phase with 5% citric acid aqueous solution, and combining the aqueous phases to obtain a solution containing compound B5.
[0037] In the preparation method, in step 2, the compound B5 generated by the reaction is directly used in step 3 without post-treatment.
[0038] In the preparation method, in step 3, the solvent may be a conventional solvent for such reactions in the art, such as an ether solvent, preferably tetrahydrofuran.
[0039] In the preparation method, in step 3, the base may be an inorganic base, such as potassium bicarbonate.
[0040] In the preparation method, in step 3, the molar ratio of the compound B5 to the benzyl chloroformate can be 1:(1-2); preferably 1:1.
[0041] In the preparation method, in step 3, the molar ratio of the compound B5 to the base can be 1:(1-5); preferably 1:2.
[0042] In the preparation method, in step 3, the reaction temperature can be 20-30°C.
[0043] In the preparation method, step 3 comprises the following steps: adding 30% sodium hydroxide solution to the solution containing compound B5 obtained in step 2 at 15-25°C, adjusting the pH of the system to 7-8, mixing with tetrahydrofuran, benzyl chloroformate (CbzCl) and potassium bicarbonate, reacting at 20-30°C, and obtaining compound B6 through post-treatment.
[0044] In the preparation method, in step 3, the post-treatment comprises the following steps: after the reaction is completed, adjusting the pH of the reaction solution to 1, extracting with an ester organic solvent, concentrating the organic phase and cooling it to 20-30° C., dropping n-heptane, and filtering to obtain compound B6;
[0045] More preferably, the filter cake is washed with an ester organic solvent / n-heptane mixed solution and dried; or, the process further comprises: recrystallizing the dried solid with water and ethanol to obtain compound B6.
[0046] In the preparation method, in step 4, the solvent may be a mixed solvent of dichloromethane, tetrahydrofuran and water; the volume ratio of dichloromethane, tetrahydrofuran and water is preferably 17:3:1.
[0047] In the preparation method, in step 4, the base may be an organic base, such as triethylamine.
[0048] In the preparation method, in step 4, the molar ratio of the compound B6 to the base can be 1:(0.02~0.1); preferably 1:0.02.
[0049] In the preparation method, in step 4, the molar ratio of the compound B6 to the potassium phosphate can be 1:(1-2); preferably 1:1.2.
[0050] In the preparation method, in step 4, the molar ratio of the compound B6 to the p-toluenesulfonyl chloride can be 1:(0.4~1); preferably 1:0.46.
[0051] In the preparation method, in step 4, the molar ratio of the compound B6 to the di-tert-butyltin dichloride can be 1:(0.05~0.1); preferably 1:0.05.
[0052] In the preparation method, in step 4, the reaction temperature can be 20-30°C.
[0053] In the preparation method, in step 4, the reaction is carried out under the protection of an inert gas, such as nitrogen.
[0054] In the preparation method, in step 4, the reaction comprises the following steps: under nitrogen protection, in a mixed solution of dichloromethane, tetrahydrofuran and water at 20-30° C., compound B6 and potassium phosphate are mixed, di-tert-butyltin dichloride, triethylamine and p-toluenesulfonyl chloride are added, and after the reaction is complete, extraction is performed, and the organic phase is separated to obtain a dichloromethane solution containing compound B7; preferably, the dichloromethane solution containing compound B7 is concentrated and directly used in step 5.
[0055] In the preparation method, in step 5, the solvent may be a conventional solvent for such reactions in the art, such as toluene.
[0056] In the preparation method, in step 5, the acid may be one or both of glacial acetic acid and p-toluenesulfonic acid.
[0057] In the preparation method, in step 5, the molar ratio of the compound B7 to the 3,4-dihydropyran can be 1:(1-5); preferably 1:2.
[0058] In the preparation method, in step 5, the molar ratio of the compound B7 to the glacial acetic acid can be 1:(0.5~1); preferably 1:0.5.
[0059] In the preparation method, in step 5, the molar ratio of the compound B7 to the p-toluenesulfonic acid can be 1:(0.5-1); preferably 1:0.5. The p-toluenesulfonic acid is preferably p-toluenesulfonic acid monohydrate.
[0060] In the preparation method, in step 5, the reaction temperature can be 15-25°C.
[0061] In the preparation method, step 5 comprises the following steps: concentrating the dichloromethane solution containing compound B7 obtained in step 4, mixing and concentrating with toluene, and reacting with glacial acetic acid, p-toluenesulfonic acid monohydrate and 3,4-dihydropyran at 15-25° C. to obtain a solution containing compound B7-1.
[0062] In the preparation method, in step 6, the base may be an organic base, such as potassium tert-butoxide.
[0063] In the preparation method, in step 6, the molar ratio of the compound B7-1 to the base can be 1:(1-5); preferably 1:2.
[0064] In the preparation method, in step 6, the reaction temperature can be 15-25°C.
[0065] In the preparation method, step 6 comprises the following steps: at 5-15°C, the solution containing compound B7-1 obtained in step 5 is mixed with potassium tert-butoxide, and reacted at 15-25°C; after the reaction is completed, acid is added for neutralization, the mixture is allowed to stand for stratification, the aqueous phase is extracted with toluene, and the organic phase is concentrated under reduced pressure to obtain a toluene solution containing compound B7-2; preferably, it is directly used in step 7.
[0066] In the preparation method, in step 7, the solvent may be a conventional solvent for such reactions in the art, such as an alcohol solvent, such as methanol.
[0067] In the preparation method, in step 7, the acid may be one or both of p-toluenesulfonic acid and hydrogen chloride; the p-toluenesulfonic acid is preferably p-toluenesulfonic acid monohydrate; the hydrogen chloride is preferably a hydrogen chloride ethanol solution; and the concentration of the hydrogen chloride ethanol solution is preferably 4M.
[0068] In the preparation method, in step 7, the reaction temperature can be 15-25°C.
[0069] In the preparation method, in step 7, the molar ratio of the compound B7-2 to the p-toluenesulfonic acid can be 1:(0.1~1); preferably 1:0.1.
[0070] In the preparation method, in step 7, the molar ratio of the compound B7-2 to the hydrogen chloride can be 1:(0.5~1); preferably 1:0.77.
[0071] In the preparation method, in step 7, the reaction is carried out under the protection of an inert gas, such as nitrogen.
[0072] In the preparation method, step 7 comprises the following steps: under nitrogen protection, the toluene solution containing compound B7-2 obtained by the reaction in step 6 is mixed with methanol, p-toluenesulfonic acid monohydrate and hydrogen chloride ethanol solution, and reacted at 15-25° C. to obtain a toluene solution containing compound B8; preferably, it is directly used in step 8.
[0073] In the preparation method, in step 8, the reactants of the Mitsunobu reaction further include triphenylphosphine and di-tert-butyl azodicarboxylate (DBAD).
[0074] In the preparation method, in step 8, the molar ratio of the compound B8 to the compound B8-1 can be 1:(0.5-1.2); preferably 1:0.9.
[0075] In the preparation method, in step 8, the molar ratio of the compound B8 to the triphenylphosphine can be 1:(1-2); preferably 1:1.4.
[0076] In the preparation method, in step 8, the molar ratio of the compound B8 to the di-tert-butyl azodicarboxylate can be 1:(1-2); preferably 1:1.4.
[0077] In the preparation method, in step 8, the solvent may be a conventional solvent for such reactions in the art, such as toluene.
[0078] In the preparation method, in step 8, the reaction is carried out under the protection of an inert gas, such as nitrogen.
[0079] In the preparation method, in step 8, the temperature of the Mitsunobu reaction can be -7 to 3°C.
[0080] In the preparation method, in step 8, the Mitsunobu reaction comprises the following steps: under nitrogen protection, the toluene solution containing compound B8 obtained in step 7 is mixed with toluene, compound B8-1 and triphenylphosphine, di-tert-butyl azodicarboxylate (DBAD) toluene solution is added dropwise at -7 to 3°C, and anhydrous magnesium chloride is added to react to obtain compound B9.
[0081] In the preparation method, in step 9, the solvent may be a conventional solvent for such reactions in the art, such as toluene.
[0082] In the preparation method, in step 9, the molar ratio of the compound B9 to the ethanolamine can be 1:(2-10); preferably 1:4.
[0083] In the preparation method, in step 9, the reaction temperature can be 45-55°C.
[0084] In the preparation method, in step 9, the reaction is carried out under the protection of an inert gas, such as nitrogen.
[0085] In the preparation method, in step 10, the solvent may be a conventional solvent for such reactions in the art, such as ethyl acetate.
[0086] In the preparation method, in step 10, the acid may be a hydrogen chloride ethyl acetate solution.
[0087] In the preparation method, in step 10, the reaction temperature can be 45-55°C.
[0088] The present invention also provides a compound B4 or a salt thereof,
[0089] .
[0090] The present invention also provides a method for preparing compound B4, which comprises the following steps: in a solvent, compound B3, ethyl Grignard reagent, titanate and boron trifluoride reagent react to generate compound B4;
[0091] ;
[0092] Wherein, the preparation conditions of the preparation method of the compound B4 are as described in any scheme of the present invention.
[0093] The present invention also provides a compound B5 or a salt thereof,
[0094] .
[0095] The present invention also provides a method for preparing compound B5, which comprises the following steps: compound B4 reacts with an acid to generate compound B5;
[0096]
[0097] The preparation conditions of the preparation method of the compound B5 are as described in any scheme of the present invention.
[0098] Preferably, the preparation method of the compound B5 also includes the preparation of the compound B4; the preparation conditions of the compound B4 are as described in any scheme of the present invention.
[0099] The present invention also provides a compound B6 or a salt thereof,
[0100] .
[0101] The present invention also provides a method for preparing compound B6, which comprises the following steps: in a solvent, compound B5 reacts with benzyl chloroformate (CbzCl) and a base to generate compound B6;
[0102]
[0103] The preparation conditions of the preparation method of the compound B6 are as described in any scheme of the present invention.
[0104] Preferably, the preparation method of compound B6 also includes the preparation of compound B5; the preparation conditions of compound B5 are as described in any scheme of the present invention.
[0105] The present invention also provides a compound B7 or a salt thereof,
[0106] .
[0107] The present invention also provides a method for preparing compound B7, which comprises the following steps: in a solvent, in the presence of a base and potassium phosphate, compound B6 reacts with p-toluenesulfonyl chloride (TsCl) and di-tert-butyltin dichloride (Bu2SnCl2) to generate compound B7;
[0108]
[0109] The preparation conditions of the preparation method of the compound B7 are as described in any scheme of the present invention.
[0110] Preferably, the preparation method of the compound B7 also includes the preparation of the compound B6; the preparation conditions of the compound B6 are as described in any scheme of the present invention.
[0111] The present invention also provides a compound B7-1 or a salt thereof,
[0112] .
[0113] The present invention also provides a method for preparing compound B7-1, which comprises the following steps: in a solvent, in the presence of an acid, reacting compound B7 with 3,4-dihydropyran to generate compound B7-1;
[0114]
[0115] The preparation conditions of the preparation method of the compound B7-1 are as described in any scheme of the present invention.
[0116] Preferably, the preparation method of compound B7-1 also includes the preparation of compound B7; the preparation conditions of compound B7 are as described in any scheme of the present invention.
[0117] The present invention also provides a compound B7-2 or a salt thereof,
[0118] .
[0119] The present invention also provides a method for preparing compound B7-2, which comprises the following steps: in a solvent, compound B7-1 reacts with a base to generate compound B7-2;
[0120]
[0121] The preparation conditions of the preparation method of the compound B7-2 are as described in any scheme of the present invention.
[0122] Preferably, the preparation method of the compound B7-2 also includes the preparation of the compound B7-1; the preparation conditions of the compound B7-1 are as described in any scheme of the present invention.
[0123] The present invention also provides a compound B8 or a salt thereof,
[0124] .
[0125] The present invention also provides a method for preparing compound B8, comprising the following steps: in a solvent, compound B7-2 reacts with an acid to generate compound B8;
[0126]
[0127] The preparation conditions of the preparation method of the compound B8 are as described in any scheme of the present invention.
[0128] Preferably, the preparation method of the compound B8 also includes the preparation of the compound B7-2; the preparation conditions of the compound B7-2 are as described in any scheme of the present invention.
[0129] The present invention also provides a compound B9 or a salt thereof,
[0130] .
[0131] The present invention also provides a method for preparing compound B9, comprising the following steps: in a solvent, compound B8 and compound B8-1 undergo Mitsunobu reaction to generate compound B9;
[0132]
[0133] The preparation conditions of the preparation method of the compound B9 are as described in any scheme of the present invention.
[0134] Preferably, the preparation method of the compound B9 also includes the preparation of the compound B8; the preparation conditions of the compound B8 are as described in any scheme of the present invention.
[0135] The present invention also provides a compound B10 or a salt thereof,
[0136] .
[0137] The present invention also provides a method for preparing compound B10, which comprises the following steps:
[0138]
[0139] The preparation conditions of the preparation method of the compound B10 are as described in any scheme of the present invention.
[0140] Preferably, the preparation method of the compound B10 also includes the preparation of the compound B9; the preparation conditions of the compound B9 are as described in any scheme of the present invention.
[0141] On the basis of being in accordance with the common sense in the art, the above-mentioned preferred conditions can be arbitrarily combined to obtain the preferred embodiments of the present invention.
[0142] The reagents and raw materials used in the present invention are commercially available.
[0143] The positive improvement effect of the present invention is that the intermediate preparation method provided by the present invention has short steps, simple operation, higher yield and higher purity. DETAILED DESCRIPTION
[0144] The present invention is further described below by way of examples, but the present invention is not limited to the scope of the examples. The experimental methods in the following examples without specifying specific conditions are carried out according to conventional methods and conditions, or selected according to the product specifications.
[0145] Example 1: Synthesis of Compound I
[0146]
[0147] 1 Synthesis of compound B6
[0148] Under nitrogen protection, 150.2 kg of methyl tert-butyl ether, 20.2 kg of compound B3 and 40.8 kg of tetraisopropyl titanate (Ti(OiPr)4) were added to the reactor, 280.2 kg of 1.0 M ethylmagnesium bromide was added dropwise at a temperature of 10-20°C, and sampling was performed to detect the reaction until the reaction was complete. At this temperature, 36.4 kg of boron trifluoride ether was added dropwise, and the reaction was continued to stir for 6 hours, and sampling was performed to detect the reaction until the reaction was complete; a solution containing compound B4 was obtained.
[0149] After the reaction is completed, 185.2 kg of 25% citric acid aqueous solution is added dropwise to the reaction solution at 20-40°C, stirred at 15-35°C for 6 hours, and allowed to stand for stratification. The organic phase is extracted with 67.4 kg of 5% citric acid aqueous solution, and the aqueous phase is combined. The aqueous phase is added to the reactor, the temperature is controlled at 15-25°C, and the pH of the system is adjusted to 7-8 with 30% sodium hydroxide solution. 57.0 kg of tetrahydrofuran, 21.6 kg of benzyl chloroformate (CbzCl) and 25.0 kg of potassium bicarbonate are added. Stir at 20-30°C for 30 minutes, and sample and detect until the reaction is complete; a solution containing compound B5 is obtained.
[0150] After the reaction is completed, adjust the pH of the system to 1 with 31% concentrated hydrochloric acid at 10-30°C, add 278.4 kg of isopropyl acetate, stir, let stand for stratification, extract the aqueous phase once with 278.8 kg of isopropyl acetate, combine the organic phases, concentrate the organic phase under reduced pressure to 6-7 times the volume, cool to 20-30°C, continue stirring for 4 hours, slowly add 217.8 kg of n-heptane, continue stirring for 8 hours, filter, wash the filter cake with a mixed solution of 18.4 kg isopropyl acetate / 43.2 kg n-heptane, and dry the wet product. The dried solid, 114.4 kg of water and 22.6 kg of ethanol were added to the reactor, heated to 50-60 °C, stirred until dissolved, cooled to 35-41 °C, added with 0.038 kg of seed crystals, stirred for 2 hours, and continued to add 229.2 kg of water, stirred for 2 hours, cooled to 15-25 °C, stirred for 4 hours, filtered, and the filter cake was washed with 50 kg of water. The wet product was dried to obtain 10.8 kg of compound B6 as a white solid with a purity of 98.9%, an ee value of 99.1%, a yield of 30%, and MS: m / z=280.18, [M+H] + .
[0151] 2. Synthesis of compound B7
[0152] Under nitrogen protection, add 106.0kg of dichloromethane, 18.2kg of tetrahydrofuran, 6.0kg of water, 20.2kg of compound B6 and 18.2kg of potassium phosphate to the reactor, stir at 20-30°C for 30 minutes, add 1.09kg of di-tert-butyltin dichloride (Bu2SnCl2), 0.14kg of triethylamine and 15.0kg of p-toluenesulfonyl chloride (TsCl), stir at 20-30°C for 10-12 hours, and take samples for detection until the reaction is complete. Add 80.1kg of water, stir for 4 hours, let stand to separate, wash the organic phase with 84.6kg of 5% sodium chloride solution, and obtain 170.7kg of compound B7 in dichloromethane solution with a purity of 90.6%, MS: m / z=434.15, [M+H] + .
[0153] 3. Synthesis of compound B8
[0154] Add 170.7kg of dichloromethane solution of compound B7 to the reactor, concentrate under reduced pressure to 2-3 times the volume, add 173.4kg of toluene, continue to concentrate to 8-10 times the volume, control the temperature at 15-25°C, add 2.2kg of glacial acetic acid, 0.68kg of p-toluenesulfonic acid monohydrate and 12.0kg of 3,4-dihydropyran, continue to stir for 2 hours, and take samples to detect the reaction is complete; obtain the solution of compound B7-1. Cool down to 5-15°C, add 16.1kg of potassium tert-butoxide at this temperature, heat to 15-25°C and continue to stir for 4 hours, take samples to detect the reaction is complete. At this temperature, add 160.5kg of 1.8% hydrochloric acid solution to the reaction solution, continue to stir for 2 hours, stand for stratification, extract the aqueous phase once with 33.8kg of toluene, combine the organic phases, and concentrate the organic phase under reduced pressure to 8 times the volume to obtain the toluene solution of compound B7-2.
[0155] Under nitrogen protection, the toluene solution of the above-mentioned compound B7-2, 47.8 kg of methanol, 1.4 kg of p-toluenesulfonic acid monohydrate and 11.5 kg of 4M hydrogen chloride ethanol solution were added to the reactor, stirred at 15-25 ° C for 1 hour, and samples were taken for detection until the reaction was complete. The reaction solution was temperature-controlled at 15-25 ° C and added dropwise to 160.5 kg of 5% potassium bicarbonate solution, and continued to stir for 1 hour. The filter cake was filtered with diatomaceous earth, and the filter cake was washed with 34.9 kg of toluene. The filtrate was combined, and the stratification was allowed to stand. The aqueous phase was extracted once with 35.2 kg of toluene, and the organic phases were combined. The organic phases were concentrated to 4 times the volume under reduced pressure, and 76.0 kg of toluene was added to obtain 153.3 kg of toluene solution of compound B8, with a purity of 88.6%, MS: m / z=262.20, [M+H] + .
[0156] 4. Synthesis of compound B9
[0157] Under nitrogen protection, add 210.3kg of toluene solution of compound B8, 52.3kg of toluene, 16.1kg of compound B8-1 and 28.0kg of triphenylphosphine to the reactor, cool to -7~3°C, add di-tert-butyl azodicarboxylate (DBAD) toluene solution (25.0kg DBAD and 87.3kg toluene) to the reaction solution, continue stirring for 6 hours, and take samples to detect the reaction is complete. Add 14.6kg of anhydrous magnesium chloride, continue stirring for 1 hour, heat to 20~30°C, continue stirring for 60 hours, and take samples to detect the reaction is complete. Filter the reaction solution with diatomaceous earth pad, rinse the filter cake with 22.4kg toluene, and combine the filtrate. 280.5 kg of 4N hydrochloric acid was added to the filtrate, stirred at 20-30 °C for 24 hours, and allowed to stand for stratification. The organic phase was washed with 84.1 kg of 10% sodium chloride solution, then with 84.4 kg of a mixed solution of 4% sodium chloride and 4% sodium bicarbonate, and then with 83.4 kg of 10% sodium chloride solution. The organic phase was concentrated under reduced pressure to 8 times the volume to obtain 225.1 kg of a toluene solution of compound B9 with a purity of 80.9%. MS: m / z=506.21, [M+H] + .
[0158] 5. Synthesis of compound B10
[0159] Under nitrogen protection, add 224.5kg of toluene solution of compound B9 and 12.9kg of ethanolamine to the reactor, heat to 45~55℃, continue stirring for 16 hours, and take samples for detection until the reaction is complete. Cool to 10~20℃, add 175.4kg of 3% dilute hydrochloric acid, stir, stand for stratification, wash the organic phase with 125.2g of water twice (125.2g*2), concentrate the organic phase under reduced pressure until there is no obvious fraction, add 60.0kg of ethyl acetate, and obtain 93.5kg of ethyl acetate solution of compound B10 with a purity of 53.1%, MS: m / z=376.23, [M+H] + .
[0160] 6 Synthesis of Compound I
[0161] Under nitrogen protection, 1255.2 kg of ethyl acetate solution of compound B10 was added to the reaction bottle, and the mixture was concentrated under reduced pressure until no obvious fraction was found. 1050 kg of ethyl acetate and 315.0 kg of 4.0 M hydrogen chloride ethyl acetate solution were added, and the temperature was raised to 45-55 ° C, and the mixture was stirred for 6 hours. The mixture was sampled and tested until the reaction was complete. The mixture was cooled to 20-30 ° C, 205.2 kg of ethanol was added, and the mixture was stirred for 2 hours. The mixture was filtered, and the filter cake was washed with 122.2 kg of ethyl acetate. The wet product was dried to obtain 46.1 kg of compound I. The purity was 97.2%, and the total yield of compounds B6 to I was 24.6%.
[0162] 1H NMR, DMSO-d6, 7.376~7.286(m, 9 H), 6.086(s, 2 H), 4.034~ 3.987(d, 1H),3.081~3.003(m, 2 H),2.017~1.980(m, 1 H),1.623 (m, 2 H), 1.595(m, 1 H),1.073~1.039(m, 1 H) ,0.815~0.783(m, 1 H) ,0.662~0.632(m, 1 H) ,0.558~0.527(m,1 H)。
Claims
1. A method for preparing a compound as shown in formula I, characterized in that: It includes the following steps: ; Step 1, in a solvent, compound B3, ethyl Grignard reagent, titanate and boron trifluoride reagent react to generate compound B4; Step 2, compound B4 reacts with an acid to generate compound B5; Step 3, in a solvent, compound B5 reacts with benzyl chloroformate (CbzCl) and a base to generate compound B6; Step 4, in a solvent, in the presence of a base and potassium phosphate, compound B6 reacts with p-toluenesulfonyl chloride (TsCl) and di-tert-butyltin dichloride (Bu2SnCl2) to generate compound B7; Step 5, in a solvent and in the presence of an acid, compound B7 reacts with 3,4-dihydropyran to generate compound B7-1; Step 6, in a solvent, compound B7-1 reacts with a base to generate compound B7-2; Step 7, in a solvent, compound B7-2 reacts with an acid to generate compound B8; Step 8, in a solvent, compound B8 and compound B8-1 undergo Mitsunobu reaction to generate compound B9; Step 9, in a solvent, compound B9 reacts with ethanolamine to generate compound B10; Step 10, in a solvent, compound B10 reacts with an acid to generate compound I.
2. The preparation method according to claim 1, characterized in that In step 1, one or more of the following conditions are met: (1) The solvent is an ether solvent, preferably methyl tert-butyl ether; (2) The ethyl Grignard reagent is ethylmagnesium bromide; (3) The concentration of the ethyl Grignard reagent is 1 M; (4) The titanate is tetraisopropyl titanate; (5) The boron trifluoride reagent is boron trifluoride ether; (6) The concentration of the compound B3 in the solvent is 0.1-1 kg / L, preferably 0.1 kg / L; (7) The molar ratio of the compound B3 to the ethyl Grignard reagent is 1:(10-20); preferably 1:16; (8) The molar ratio of the compound B3 to the titanate is (0.5-2):1; preferably 0.9:1; (9) The molar ratio of the compound B3 to the boron trifluoride reagent is (0.5-1):1; preferably 0.52:1; (10) The reaction temperature is 10-20°C; (11) The reaction is carried out under the protection of an inert gas, such as nitrogen; (12) Step 1 comprises the following steps: under nitrogen protection, adding compound B3 and tetraisopropyl titanate to methyl tert-butyl ether, adding ethyl magnesium bromide dropwise at 10-20° C., and after the reaction is complete, continuing to add boron trifluoride ether dropwise at 10-20° C. to obtain a solution containing compound B4; (13) The resulting compound B4 is directly used in step 2 without post-treatment.
3. The preparation method according to claim 1, characterized in that: In step 2, one or more of the following conditions are met: (1) The acid is a citric acid aqueous solution; the concentration of the citric acid aqueous solution is preferably 25% or 5%; (2) The molar ratio of the compound B4 to the acid is 1:(1-2); preferably 1:1.8; (3) The reaction temperature is 20-40°C; (4) Step 2 comprises the following steps: adding 25% citric acid aqueous solution to the solution containing compound B4 obtained in step 1 at 20-40°C, stirring at 15-35°C, standing to separate layers, extracting the organic phase with 5% citric acid aqueous solution, and combining the aqueous phases to obtain a solution containing compound B5; (5) The compound B5 produced by the reaction is directly used in step 3 without post-treatment.
4. The preparation method according to claim 1, characterized in that: In step 3, one or more of the following conditions are met: (1) The solvent is an ether solvent, preferably tetrahydrofuran; (2) The base is an inorganic base, such as potassium bicarbonate; (3) The molar ratio of the compound B5 to the benzyl chloroformate is 1:(1-2); preferably 1:1; (4) The molar ratio of the compound B5 to the base is 1:(1-5); preferably 1:2; (5) The reaction temperature is 20-30°C; (6) Step 3 comprises the following steps: adding 30% sodium hydroxide solution to the solution containing compound B5 obtained in step 2 at 15-25°C, adjusting the pH of the system to 7-8, mixing with tetrahydrofuran, benzyl chloroformate (CbzCl) and potassium bicarbonate, reacting at 20-30°C, and obtaining compound B6 after post-treatment; Preferably, the post-treatment comprises the following steps: after the reaction is completed, adjusting the pH of the reaction solution to 1, extracting with an ester organic solvent, concentrating the organic phase and cooling it to 20-30° C., dropping n-heptane, filtering, and obtaining compound B6; More preferably, the filter cake is washed with an ester organic solvent / n-heptane mixed solution and dried; or, the process further comprises: recrystallizing the dried solid with water and ethanol to obtain compound B6.
5. The preparation method according to claim 1, characterized in that: In step 4, one or more of the following conditions are met: (1) The solvent is a mixed solvent of dichloromethane, tetrahydrofuran and water; the volume ratio of dichloromethane, tetrahydrofuran and water is preferably 17:3:1; (2) The base is an organic base, such as triethylamine; (3) The molar ratio of the compound B6 to the base is 1:(0.02-0.1); preferably 1:0.02; (4) The molar ratio of the compound B6 to the potassium phosphate is 1:(1-2); preferably 1:1.2; (5) The molar ratio of the compound B6 to the p-toluenesulfonyl chloride is 1:(0.4-1); preferably 1:0.46; (6) The molar ratio of the compound B6 to the di-tert-butyltin dichloride is 1:(0.05-0.1); preferably 1:0.05; (7) The reaction temperature is 20-30°C; (8) The reaction is carried out under the protection of an inert gas, such as nitrogen; (9) The reaction comprises the following steps: under nitrogen protection, in a mixed solution of dichloromethane, tetrahydrofuran and water at 20-30° C., compound B6 and potassium phosphate are mixed, di-tert-butyltin dichloride, triethylamine and p-toluenesulfonyl chloride are added, and after the reaction is complete, extraction is performed, and the organic phase is separated to obtain a dichloromethane solution containing compound B7; preferably, the dichloromethane solution containing compound B7 is concentrated and directly used in step 5.
6. The preparation method according to claim 1, characterized in that: In step 5, one or more of the following conditions are met: (1) The solvent is toluene; (2) The acid is one or both of glacial acetic acid and p-toluenesulfonic acid; (3) The molar ratio of the compound B7 to the 3,4-dihydropyran is 1:(1-5); preferably 1:2; (4) The molar ratio of the compound B7 to the glacial acetic acid is 1:(0.5-1); preferably 1:0.5; (5) The molar ratio of the compound B7 to the p-toluenesulfonic acid is 1:(0.5-1); preferably 1:0.5; the p-toluenesulfonic acid is preferably p-toluenesulfonic acid monohydrate; (6) The reaction temperature is 15-25°C; (7) Step 5 comprises the following steps: mixing the compound B7 obtained in step 4 with toluene, and reacting the mixture with glacial acetic acid, p-toluenesulfonic acid monohydrate and 3,4-dihydropyran at 15-25° C. to obtain a solution containing compound B7-1; preferably, the solution is directly used in step 6.
7. The preparation method according to claim 1, characterized in that: In step 6, one or more of the following conditions are met: (1) The base is an organic base, such as potassium tert-butoxide; (2) The molar ratio of the compound B7-1 to the base is 1:(1-5); preferably 1:2; (3) The reaction temperature is 15-25°C; (4) Step 6 comprises the following steps: mixing the solution containing compound B7-1 obtained in step 5 with potassium tert-butoxide at 5-15°C, and reacting at 15-25°C; adding acid to neutralize after the reaction, standing to separate the layers, extracting the aqueous phase with toluene, and concentrating the organic phase under reduced pressure to obtain a toluene solution containing compound B7-2; preferably, the solution is directly used in step 7.
8. The preparation method according to claim 1, characterized in that: In step 7, one or more of the following conditions are met: (1) The solvent is an alcohol solvent, such as methanol; (2) The acid is one or both of p-toluenesulfonic acid and hydrogen chloride; the p-toluenesulfonic acid is preferably p-toluenesulfonic acid monohydrate; the hydrogen chloride is preferably a hydrogen chloride ethanol solution; the concentration of the hydrogen chloride ethanol solution is preferably 4M; (3) The reaction temperature is 15-25°C; (4) The molar ratio of the compound B7-2 to the p-toluenesulfonic acid is 1:(0.1~1); preferably 1:0.1; (5) The molar ratio of the compound B7-2 to the hydrogen chloride is 1:(0.5-1); preferably 1:0.77; (6) The reaction is carried out under the protection of an inert gas, such as nitrogen; (7) Step 7 comprises the following steps: under nitrogen protection, mixing the toluene solution containing compound B7-2 obtained by the reaction in step 6 with methanol, p-toluenesulfonic acid monohydrate and ethanolic hydrogen chloride solution, and reacting at 15-25° C. to obtain a toluene solution containing compound B8; preferably, the toluene solution is directly used in step 8.
9. The preparation method according to claim 1, characterized in that: In step 8, one or more of the following conditions are met: (1) The reactants of the Mitsunobu reaction further include triphenylphosphine and di-tert-butyl azodicarboxylate; Preferably, the molar ratio of the compound B8 to the triphenylphosphine is 1:(1-2); preferably 1:1.4; and / or, the molar ratio of the compound B8 to the di-tert-butyl azodicarboxylate is 1:(1-2); preferably 1:1.4; (2) The molar ratio of the compound B8 to the compound B8-1 is 1:(0.5-1.2); preferably 1:0.9; (3) The solvent is toluene; (4) The reaction is carried out under the protection of an inert gas, such as nitrogen; (5) The temperature of the Mitsunobu reaction is -7 to 3°C; (6) The Mitsunobu reaction comprises the following steps: under nitrogen protection, the toluene solution containing compound B8 obtained in step 7 is mixed with toluene, compound B8-1 and triphenylphosphine, di-tert-butyl azodicarboxylate (DBAD) toluene solution is added dropwise at -7 to 3°C, and anhydrous magnesium chloride is added to react to obtain compound B9.
10. The preparation method according to claim 1, characterized in that: It meets one or more of the following conditions: (1) In step 9, the solvent is toluene; (2) In the step 9, the molar ratio of the compound B9 to the ethanolamine is 1:(2-10); preferably 1:4; (3) In step 9, the reaction temperature is 45-55°C; (4) In step 9, the reaction is carried out under the protection of an inert gas, such as nitrogen; (5) In step 10, the solvent is ethyl acetate; (6) In step 10, the acid is a solution of hydrogen chloride in ethyl acetate; (7) In step 10, the reaction temperature is 45-55°C.
Citation Information
Patent Citations
5-Aminopyrazole carboxamide derivatives as BTK inhibitors, their preparation methods and pharmaceutical compositions thereof
CN107382973B
5-aminopyrazole formamide derivative as BTK inhibitor, preparation method and pharmaceutical composition thereof
CN107382973A
5-amino pyrazole carboxamide compound as btk inhibitor and preparation method thereof
CN111225912A
3 , 5-substitgued piperidine compounds as renin inhibitors
WO2007077005A1
